# Mechanism of interaction between the transactivation domain of N-myc and the DNA-binding surface of TFIIIC5

**Authors:** Eoin Leen, Sharon Yeoh, Eka Sahak, Ellie Mitchell, Gemma Wildsmith, Matthew Batchelor, Antonio N Calabrese, Gabriele Büchel, Richard Bayliss

PMC · DOI: 10.1093/nar/gkag181 · Nucleic Acids Research · 2026-02-27

## TL;DR

This study reveals how the N-myc protein interacts with TFIIIC5, a component of a key RNA transcription complex, through detailed structural and biochemical experiments.

## Contribution

The study identifies the DNA-binding domain of TFIIIC5 as a specific binding site for N-myc and provides a structural model for their interaction.

## Key findings

- The DNA-binding domain of TFIIIC5 interacts with two regions in the transactivation domain of N-myc.
- AlphaFold modeling predicts a binding mode for N-myc that overlaps with the C-terminal acidic plug of TFIIIC5.
- Removing the acidic plug of TFIIIC5 enhances N-myc binding, suggesting a competitive interaction with DNA.

## Abstract

N-myc is a transcription factor, a powerful driver of cellular growth and an important oncoprotein. N-myc interacts with many factors, including the RNA Polymerase III assembly factor, TFIIIC, a six-subunit complex that is essential for the transcription of small, structured RNA. TFIIIC and N-myc mutually restrict each other’s chromatin association, and their complex contributes to quality control in mRNA transcription. We previously demonstrated that the intrinsically disordered transactivation domain of N-myc interacts directly with a sub-complex of TFIIIC, τA. Structural studies by others show that DNA binding of τA is largely mediated by TFIIIC3, leaving open the role of the DNA-binding domain of TFIIIC5. Here, we demonstrate that this domain is a binding site for two regions in the transactivation domain of N-myc, through an integrated approach combining NMR spectroscopy, hydrogen–deuterium exchange mass spectrometry, and interaction assays (pull-downs, ITC, fluorescence polarization, and co-immunoprecipitation). AlphaFold modelling predicts with high-confidence a binding mode for the higher affinity N-myc motif that overlaps with the predicted intramolecular binding site of the C-terminal acidic plug of TFIIIC5, removal of which enhances the binding of N-myc. This model elucidates how the N-myc:TFIIIC5 interaction competes with DNA and other interactions, providing a basis for their mutual regulation.

Graphical Abstract

## Linked entities

- **Genes:** MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613], TFIIIC3 (transcription factor IIIC-gamma subunit) [NCBI Gene 8621494]
- **Proteins:** MYCN (MYCN proto-oncogene, bHLH transcription factor), TFIIIC3 (transcription factor IIIC-gamma subunit), TA (tRNA-Ala)

## Full-text entities

- **Genes:** MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613] {aka FGLDS1, MODED, MPAPA, MYCNsORF, MYCNsPEP, N-myc}, TAF1 (histone acetyltransferase) [NCBI Gene 853191] {aka KAT4, TAF130, TAF145}, GTF3A (general transcription factor IIIA) [NCBI Gene 2971] {aka AP2, TFIIIA}, DNAJC7 (DnaJ heat shock protein family (Hsp40) member C7) [NCBI Gene 7266] {aka DJ11, DJC7, TPR2, TTC2}, KAP114 (karyopherin KAP114) [NCBI Gene 852610], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, BDP1 (BDP1 general transcription factor IIIB subunit) [NCBI Gene 55814] {aka DFNB112, HSA238520, TAF3B1, TFC5, TFIIIB'', TFIIIB150}, TRM-CAT1-1 (tRNA-Met (anticodon CAT) 1-1) [NCBI Gene 100189201] {aka TRNAM11}, HDX (highly divergent homeobox) [NCBI Gene 139324] {aka CXorf43, D030011N01Rik}, GTF3C1 (general transcription factor IIIC subunit 1) [NCBI Gene 2975] {aka TFIIIC, TFIIIC220, TFIIICalpha}, SPT15 (TATA-binding protein) [NCBI Gene 856891] {aka BTF1, TBP1}, TTC1 (tetratricopeptide repeat domain 1) [NCBI Gene 7265] {aka TPR1}, BDP1 (transcription factor TFIIIB subunit BDP1) [NCBI Gene 855689] {aka TFC5, TFC7}, BIN1 (bridging integrator 1) [NCBI Gene 274] {aka AMPH2, AMPHL, CNM2, SH3P9}, MYCL (MYCL proto-oncogene, bHLH transcription factor) [NCBI Gene 4610] {aka L-Myc, LMYC, MYCL1, bHLHe38}, FLT3LG (fms related receptor tyrosine kinase 3 ligand) [NCBI Gene 2323] {aka FL, FLG3L, FLT3L, IMD125}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, POLI (DNA polymerase iota) [NCBI Gene 11201] {aka RAD30B, RAD3OB, eta2}, VCL (vinculin) [NCBI Gene 7414] {aka CMD1W, CMH15, HEL114, MV, MVCL, VINC}, MARVELD2 (MARVEL domain containing 2) [NCBI Gene 153562] {aka DFNB49, MARVD2, MRVLDC2, Tric}
- **Diseases:** Pan Cancer (MESH:D009369), DD (MESH:C536170), neuroblastoma (MESH:D009447), oncogenesis (MESH:D063646)
- **Chemicals:** streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), PEG 300 (MESH:C000595211), acetonitrile (MESH:C032159), EDTA (MESH:D004492), His (MESH:D006639), N2 (MESH:D009584), NP-40 (MESH:C010615), formic acid (MESH:C030544), TCEP (MESH:C080938), phosphate (MESH:D010710), salt (MESH:D012492), NaCl (MESH:D012965), spectinomycin (MESH:D000198), MgCl2 (MESH:D015636), FAM (MESH:C031179), glycine (MESH:D005998), kanamycin (MESH:D007612), MnCl2 (MESH:C025340), SDS (MESH:D012967), biotin (MESH:D001710), DTT (MESH:D004229), oligonucleotides (MESH:D009841), Peptide (MESH:D010455), nucleotide (MESH:D009711), D2O (MESH:D017666), H2O (MESH:D014867), pD (MESH:D010165), imidazole (MESH:C029899), amino acid (MESH:D000596), penicillin (MESH:D010406), glycerol (MESH:D005990), puromycin (MESH:D011691), HEPES (MESH:D006531), Bis (MESH:D001729), 5-carboxyfluorescein (MESH:C045132), S (MESH:D013455), 15N (-), Deuterium (MESH:D003903), Cy5 (MESH:C085321), DMSO (MESH:D004121), chloramphenicol (MESH:D002701), PVDF (MESH:C024865), Hydrogen (MESH:D006859), KCl (MESH:D011189), PBS (MESH:D007854), Tween-20 (MESH:D011136), TBS-T (MESH:C027647), polybrene (MESH:D006583), citrate (MESH:D019343), IPTG (MESH:D007544), Cobalt (MESH:D003035), borate (MESH:D001881), ampicillin (MESH:D000667)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Spleen focus-forming virus (species) [taxon 11819], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Schizosaccharomyces pombe (fission yeast, species) [taxon 4896], Mycoplasma (genus) [taxon 2093], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** W88A, Y29A, C27S, F28A, Delta345-366 Delta487, V in 0, C with 2
- **Cell lines:** pGEX-6P-1 — Homo sapiens (Human), Embryonic stem cell (CVCL_VN44), HEK293TN — Homo sapiens (Human), Transformed cell line (CVCL_UL49), pETM6T1 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_C3PU), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), pET30TEV — Mus musculus (Mouse), Hybridoma (CVCL_J925), SH-EP — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0524), BL21(DE3)-RIL — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_B7TK)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956345/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956345/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956345/full.md

---
Source: https://tomesphere.com/paper/PMC12956345